Home » Authors » Mark McCarty

Articles by Mark McCarty

CMS staffer: payments must shift to an ‘outcomes’-based system

Nov. 15, 2007

By Mark McCarty

Exact gets warning for cancer test used outside ‘home brew’ rules

Nov. 13, 2007

By Mark McCarty

CDC data confirm correlation between COPD, heart disease

Nov. 8, 2007

By Mark McCarty

Telemonitoring takes face-to-face requirement out of doctor’s visit

Nov. 8, 2007

By Mark McCarty

For-profit rehab hospitals said to be making good use of PPS

Nov. 7, 2007

By Mark McCarty

IT proliferation could change behaviors, impact of diseases

Nov. 6, 2007

By Mark McCarty

Congress seen likely to cover cuts of ‘08 Part B doctors’ fees

Nov. 5, 2007

By Mark McCarty

Panel says 'no' to non-RCTs, this time for carotid stenting

Nov. 1, 2007

By Mark McCarty

Endeavor DES gets panel thumbs-up

Nov. 1, 2007

By Mark McCarty

Telemonitoring takes face-to-face requirement out of doctor’s visit

Nov. 1, 2007

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.